The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 07, 2022
Filed:
Jan. 07, 2016
Applicant:
Etubics Corporation, Seattle, WA (US);
Inventors:
Frank R. Jones, Seattle, WA (US);
Elizabeth Gabitzsch, Seattle, WA (US);
Yvette Latchman, Seattle, WA (US);
Adrian Rice, Seattle, WA (US);
Assignee:
Etubics Corporation, Seattle, WA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/63 (2006.01); C12N 15/86 (2006.01); A61K 39/00 (2006.01); A61K 39/235 (2006.01); C07K 16/28 (2006.01); A61K 39/12 (2006.01); A61K 39/395 (2006.01); A61P 31/20 (2006.01); A61P 35/04 (2006.01); A61P 35/00 (2006.01); A61K 45/06 (2006.01); C07K 14/47 (2006.01); C07K 14/705 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 39/0011 (2013.01); A61K 39/00117 (2018.08); A61K 39/001182 (2018.08); A61K 39/12 (2013.01); A61K 39/235 (2013.01); A61K 39/39541 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); A61P 31/20 (2018.01); A61P 35/00 (2018.01); A61P 35/04 (2018.01); C07K 14/4705 (2013.01); C07K 14/70596 (2013.01); C07K 16/2818 (2013.01); C12N 7/00 (2013.01); A61K 2039/505 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/575 (2013.01); A61K 2039/585 (2013.01); A61K 2039/70 (2013.01); C07K 2317/76 (2013.01); C12N 2710/10023 (2013.01); C12N 2710/10043 (2013.01); C12N 2710/10071 (2013.01); C12N 2710/10343 (2013.01); C12N 2710/10371 (2013.01); C12N 2710/20034 (2013.01);
Abstract
Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.